We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Technique Detects Down Syndrome in Fetuses in Two Hours

By Biotechdaily staff writers
Posted on 27 Aug 2007
A new technique enables pregnant women to know whether their fetus has Down syndrome in just a few hours.

Called FlashFISH, the new technique is a modification of the existing standard fluorescence in situ hybridization (FISH) test, which provides results in 24-48 hours. More...
Another procedure, called karyotyping, delivers results between eight and 21 days.

Both FlashFISH and the standard FISH involve inserting a needle through the pregnant woman's abdominal wall to draw amniotic fluid from the womb. The amniotic fluid comes from the membranous sac, which surrounds the embryo and contains genetic material from the fetus. The FlashFISH test requires only two ml of fluid compared with 5 ml needed for standard tests. Clinicians examine fetal cells in the fluid by maneuvering a molecular probe directly into the cells' nucleus. The probe is a tiny portion of DNA that can attach to a matching sequence in the fetal cell and identify whether it is abnormal.

The new procedure was developed by assistant Prof. Mahesh Choolani, from the department of obstetrics and gynecology, National University of Singapore (NUS; Singapore), and his laboratory team. Dr Choolani reported that FlashFISH matches the accuracy of the currently used standard FISH test. He added that it poses no additional risks to the mother and costs roughly the same amount as the currently used test.

Prof. Choolani said that the test has proved to be 99% accurate in detecting Down syndrome. The new technique carries the same risk of miscarriage--about one in 100--as the traditional tests because it involves inserting a needle into the womb.

The test particularly will be useful for women who become pregnant after age 35 because they are more at risk for having a child with Down syndrome. Prof. Choolani said that they had decided to develop a faster test because, Waiting for test results can cause a lot of anxiety in couples.


Related Links:
National University of Singapore

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Alzheimer's Disease Biomarker Assay
Elecsys Phospho-Tau (217P) Plasma
New
Neurofilament Light Chain Assay
Lumipulse G NfL Blood
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

UK Project Advances Blood-Based Dementia Testing Toward Routine Clinical Care

Dementia is the leading cause of death in the UK, accounting for almost one in eight deaths, with more than 72,000 people dying from dementia, including Alzheimer’s disease, in 2025. Despite this burden,... Read more

Microbiology

view channel
Image: Overview of a rapid diagnostic workflow for fungal bloodstream infections (Photo courtesy of Professor Hiroki Takahashi and IMO, Chiba University, Japan)

Genomic Workflow Identifies Fungal Pathogens Before Blood Cultures Turn Positive

Fungal bloodstream infections pose a major threat to hospitalized patients. Candida species cause most invasive fungal infections worldwide and are among the leading causes of hospital-acquired bloodstream... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: TruVerus is designed to deliver a broad menu of routine blood tests from a small blood sample on a single, automated benchtop platform (Photo courtesy of Truvian Health)

Collaboration Advances Automated Benchtop Platform for Routine Blood Testing

Routine blood testing is central to clinical decision-making, but access can vary across laboratory and healthcare settings. Broader use of automated benchtop platforms may help integrate testing more... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.